+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Orion Corp (ORNBV) - Financial and Strategic SWOT Analysis Review

Orion Corp (ORNBV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Orion Corp (Orion) develops, manufactures and markets human and veterinary pharmaceuticals, and active pharmaceutical ingredients (APIs). Its products include pharmaceuticals for the treatment of central nervous system disorders, cancer and respiratory diseases. The company's pipeline encompasses investigational candidates for the treatment of amyotrophic lateral sclerosis, Parkinson’s disease, chronic obstructive pulmonary disease, and various cancer types. Orion’s client base consists of healthcare service providers and professionals, such as doctors, pharmacies, veterinarians, hospitals, healthcare centers, clinics and laboratories. The company sells its products in European markets through its sales network and in international markets through several partners and distributors. Orion is headquartered in Espoo, Finland.

Orion Corp Key Recent Developments

  • May 07, 2024: Orion Corporation: Change in Orion Group Executive Management Board as of 31 May 2025
  • Apr 11, 2024: Orion publishes Interim Report for January-March 2024 and Holds a Webcast on 25 April 2024
  • Mar 22, 2024: Change in Orion Group Executive Management Board: change in Orion''s group-level functions
  • Mar 20, 2024: Decisions taken by Orion Corporation’s Annual General Meeting on 20 March 2024

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Section 1 - About the Company
  • Orion Corp - Key Facts
  • Orion Corp - Key Employees
  • Orion Corp - Key Employee Biographies
  • Orion Corp - Major Products and Services
  • Orion Corp - History
  • Orion Corp - Company Statement
  • Orion Corp - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • Orion Corp - Business Description
  • Product Category: Animal Health
  • Overview
  • Performance
  • Product Category: Branded Products
  • Capital Expenditure
  • Performance
  • Product Category: Fermion and Contract Manufacturing
  • Overview
  • Performance
  • Product Category: Generics and Consumer Health
  • Overview
  • Performance
  • Product Category: Innovative Medicines
  • Overview
  • Performance
  • Product Category: Translation Differences and Other Operations
  • Performance
  • Geographical Segment: Finland
  • Performance
  • Geographical Segment: North America
  • Performance
  • Geographical Segment: Other Countries
  • Performance
  • Geographical Segment: Other Europe
  • Performance
  • Geographical Segment: Scandinavia
  • Performance
  • R&D Overview
  • Orion Corp - Corporate Strategy
  • Orion Corp - SWOT Analysis
  • SWOT Analysis - Overview
  • Orion Corp - Strengths
  • Orion Corp - Weaknesses
  • Orion Corp - Opportunities
  • Orion Corp - Threats
  • Orion Corp - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Orion Corp, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
  • Orion Corp, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024
  • Orion Corp, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • May 07, 2024: Orion Corporation: Change in Orion Group Executive Management Board as of 31 May 2025
  • Apr 11, 2024: Orion publishes Interim Report for January-March 2024 and Holds a Webcast on 25 April 2024
  • Mar 22, 2024: Change in Orion Group Executive Management Board: change in Orion''s group-level functions
  • Mar 20, 2024: Decisions taken by Orion Corporation’s Annual General Meeting on 20 March 2024
  • Feb 13, 2024: Notice to the Annual General Meeting of Orion Corporation
  • Jan 29, 2024: Orion Publishes Financial Statement Release for 2023 and Holds a Webcast on 13 February 2024
  • Jan 23, 2024: Orion Group Announces Executive Management Board
  • Jan 23, 2024: TEXEL, Supported by Swedish Government, in New Collaboration With Leading European Energy Companies, E.ON and Uniper to Create Sustainable Energy System
  • Oct 16, 2023: Orion publishes Interim Report for January-September 2023 on Thursday 26 October 2023
  • Sep 20, 2023: Change in Orion Group''s Half-Year Financial Report 2024 publication date
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Publisher
  • Contact the Publisher
  • Disclaimer
List of Tables
  • Orion Corp, Key Facts
  • Orion Corp, Key Employees
  • Orion Corp, Key Employee Biographies
  • Orion Corp, Major Products and Services
  • Orion Corp, History
  • Orion Corp, Subsidiaries
  • Orion Corp, Key Competitors
  • Orion Corp, Ratios based on current share price
  • Orion Corp, Annual Ratios
  • Orion Corp, Annual Ratios (Cont...1)
  • Orion Corp, Annual Ratios (Cont...2)
  • Orion Corp, Interim Ratios
  • Orion Corp, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
  • Orion Corp, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024
  • Orion Corp, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Orion Corp, Performance Chart (2019 - 2023)
  • Orion Corp, Ratio Charts
  • Orion Corp, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
  • Orion Corp, Pharmaceuticals & Healthcare, Deals by Type, 2018 to YTD 2024

Samples

Loading
LOADING...

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • F. Hoffmann-La Roche Ltd
  • Biohit Oyj
  • Merck & Co Inc
  • Biotie Therapies Ltd
  • Tasly Pharmaceuticals Inc
  • GSK plc
  • Abbott Laboratories